NCT00898716View on ClinicalTrials.gov

Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Neoplasms
Interventions
DRUG

BMS-754807

Tablets, Oral, 20 mg, 30 mg, 50 mg, 70 mg, 100 mg, 130 mg, 160 mg, 200 mg once daily, 3-5 months, depending on response

Trial Locations (1)

104-0045

Local Institution, Chuo-Ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY